Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Ophthalmology. 2013 Apr 10;120(8):1604–1611.e4. doi: 10.1016/j.ophtha.2013.01.021

Figure 1.

Figure 1

A. Repeated-measures estimates of the probability of development of advanced age-related macular degeneration (AMD) in at least 1 study eye of participants in Categories 3 and 4 adjusted by Age-Related Eye Disease Study (AREDS) categories and study visits. The study eye is an eye without evidence of advanced AMD, and with a visual acuity score of greater than 73 letters (20/32 or better) at baseline.

B. Repeated-measures estimates of the probability of a loss in the visual acuity score of at least 15 letters in at least 1 study eye of participants in age-related macular degeneration (AMD) Categories 3 and 4 by adjusted by AMD categories and study visits. The study eye is an eye without evidence of advanced AMD and with a visual acuity score greater than 73 letters (20/32 or better) at baseline.